| S.No |
Title of the projects & PI |
Funding Agency & No. |
Duration |
| 01 |
Characterization of a novel 88 kDa protein found in patients with Eales’ disease, Uveitis, tuberculosis, leprosy and rheumatoid arthritis
(PI: Dr. K.N. Sulochana) |
ICMR
53/9/2001 |
2 years
2011-14 |
| 02 |
Adiponectin as a “therapeutic target” for ocular angiogenesis
(PI: Dr. K.N. Sulochana) |
ICMR
5/4/6/6/09-NCD II |
3 years
2010-13 |
| 03 |
Development of siRNA by targeting copper regulators to control angiogenesis (PI: Dr. K.N. Sulochana) |
DBT
PR/2885/AGR/36/620/09 |
3 yrs
2010-13 |
| 04 |
Development of a simple fluorescent assay for serum LOX activity (PI: Dr. K.N. Sulochana) |
ICMR
52/6/2009-BMS |
2 yrs
2011-13 |
| 05 |
Design and development of small therapeutic peptide to target Angiogenesis by regulating LOX (PI: Dr. K.N. Sulochana) |
CSIR
27(0241)/10/EMR II |
3 years
2011-14 |
| 06 |
Development of therapeutic peptides from small proteoglycan LRR family for the inhibition of tumor angiogenesis. (PI: Dr. K.N. Sulochana) |
DBT PR13198/Med/30/245/09 |
3 yrs
2011-13 |
| 07 |
Development of modulators of ODC for the therapeutic application in retinoblastoma (PI: Dr. K.N. Sulochana) |
CSIR 02/105)/12/EMR II |
3 yrs
2012-15 |
| 08 |
Identification of interacting partners for PEDF in causing anti-angiogenesis (PI: Dr. K.N. Sulochana) |
DST SR/SO/JS/0099/2010 |
3 yrs
2012-15 |
| 09 |
Contact Lens wear induced changes in KC patients at the level of Redox status, inflammatory cytokines and collagen cross linking (PI: Dr. N. Angayarkanni) |
ICMR
5/4/6/16/Oph/11-NCD-II |
3yrs
2012-15 |
| 10 |
Screening of the AMD patients for PON polymorphism and its functional correlation at the level of the PON activity, OxLDL and Hcy in the blood(PI: Dr. N. Angayarkanni) |
DBT: BT/PR13630/BRB/10/776/2010 |
3 yrs
2011-14 |
| 11 |
Effect of pesticide chlorpyrifos on the proteome of human retinal pigment epithelial cell line ARPE-19. Effect of cytoprotective agents on chlorpyriphos induced cytotoxicity. (PI: Dr. N. Angayarkanni) |
ICMR-5/8/4/18(ENV)/08/NCD-1 |
3 yrs
2010-13 |
| 12 |
Investigation into the role of Lipids, Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth factor in Diabetic Retinopathy (PI: Dr. N. Angayarkanni) |
DBT
PR11627/MED/30/157 2008 |
3 yrs
2010-13 |
| 13 |
Analysis of trace elements from donor eye balls with ARMD
(PI: Dr. K Coral) |
CSIR
27(0264)/12/EMRII |
3 years
2012-15 |
| 14 |
Investigating the therapeutic potential of LOX propeptide in angiogenesis and tumorogenesis (PI: Dr. K Coral) |
DST
SR/FT/LS-139/2010 |
3 years
2012-15 |
| 15 |
Regulation of SNARE exocytotic machinery under physiological and pathological conditions of diabetes (PI: Dr. J. Subbulakshmi) |
DST SR/FT/LS-145/2010 |
3 years
2012-15 |
| 16 |
Role of adiponectin on the integrity of Blood retinal
barrier during diabetic retinopathy using an in vitro 3D
cell culture model. (PI: Dr. J. Subbulakshmi) |
DBT (RGYI) PR15023/GBD/27/282/10 |
3 years
2011-14 |
| 17 |
Understanding the effect of Adiponectin mediated signaling pathways on retinal degeneration using human retinal explant culture for designing efficient neuroprotective agent . (PI: Dr. J. Subbulakshmi) |
BT/PR055/MED/30/761/2012). |
3 years
2012-15 |
